Discover innovative single-use mixer for efficient mixing of low shear and particulate sensitive solutions in cGMP environment
ATMI Life Science
Quality System Issues Most Frequent Cause of Drug Shortages, Survey Finds
 |
Manufacturers’ quality issues were among the most prevalent reasons for drug shortages, according to a new industry survey. Related news |
News in brief
The Supreme Court has ruled that the US FTC (Federal Trade Commission) may investigate “pay-for-delay” deals between generic and brand manufacturers on a case by case basis, according to a decision with consequences for all pharma, biotech and generic companies.
The US Supreme Court has ruled unanimously that naturally occurring DNA is not patentable “merely because it has been isolated,” but synthetic DNA can be patented.
The latest technology platform from Capsugel's four-month old DFS Unit offers greater bioavailabilty and stability in oral dose formulation, says the company.
ATMI has opened a development and testing lab in the US to let customers test its single-use production and technologies.
Global Industry News
Insulin CMO Sued by US City Over Failed Manufacturing Plant from Outsourcing-Pharma.com
A US CMO that promised to make cost-effective, generic insulin has been sued by the city where it planned to set up a manufacturing plant.
DHL Launches Cold Chain Air Distribution Service from Outsourcing-Pharma.com
Logistics company DHL has launched a new temperature controlled air freight service to service for biologics.
Chiltern’s Growth Spurs New Expansion, Investments from Outsourcing-Pharma.com
Demand is at an all time high according to CRO Chiltern, which reported that its revenue grew more than 16% from the last fiscal year.
Partnership Aims to Take Advantage of Preclinical Ophthalmology Developments from Outsourcing-Pharma.com
Calvert Labs and EyeCRO have teamed up, citing growing demand for integrated early-phase services for ocular drugs.
Patheon Sees Revenue Increase in Q2 as CMO Business Thrives from Outsourcing-Pharma.com
Canadian CMO Patheon’s second quarter revenues increased almost 40 percent as the company’s commercial manufacturing services revenues saw a similarly high rise over the same period from last year.
Spotlight
  Dispatches from Excipient Fest in Baltimore - UPDATEConfusion Abounds in Elemental Impurities Testing for Pharma, ExcipientsAs the USP, ICH and US FDA all aim to tackle elemental impurities testing for pharmaceuticals and... |
 Dispatches from Excipient Fest in BaltimoreChina Looks to Tighten Excipient Regulations with Limited ResourcesChina’s implementation of GMPs for excipient manufacturers, as well as a developing US FDA-style DMF system, have... |
 Injex Gets China Approval; Glide to Make Solid-Dose Anthrax for PfenexInjex says it is looking for partners to prefill its device and Glide will develop Pfenex’s anthrax... |
 GMP Plants and BioPharma Clusters Drive Russia's Pharma 2020International GMP standard facilities and six biopharma centres will lead Russia’s initiative in implementing its Pharma 2020... |
Most Popular News
Key Industry Events
BioPharm America™ 2013—6th Annual International Partnering Conference
Boston, MA, USA / Conference